Premier Inc. Designates Kit Check as “Essential Business”

Kevin MacDonaldBlog

In this unprecedented time in America, especially in healthcare, we at Kit Check are honored to continue to support our customers. We all know that COVID-19 has already begun to present additional supply chain challenges. With our Medication Intelligence software solutions, we want to ensure that providers can focus more time on patient care, and less time navigating the medication … Read More

Bluesight Med Tracking in the Fight Against COVID-19

Jenny HarlettBlog

Every day brings new information about the fight against the COVID-19 virus. Last week it was  announced that health officials are looking at using hydroxychloroquine as a possible treatment option for patients who have tested positive for the virus and are showing symptoms. While the efficacy of the treatment is yet to be determined, it is worth knowing how much … Read More

Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report

Jenny HarlettPress Release

KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering on product support, customer loyalty and quality of operations.   WASHINGTON (January 31, 2020) — Kit Check™, the leader in automated and intelligent medication management solutions, today announced that its Bluesight™ for Controlled Substances diversion detection software has been named the Category Leader in Drug Diversion … Read More

Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders

Jenny HarlettPress Release

Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical providers relating to controlled substances management and drug diversion WASHINGTON (January 14, 2020) – Kit CheckTM, the leader in automated and intelligent medication management solutions, today announced they will be hosting a first-of-its-kind continuing education online symposium, “Current Perspectives and Future Trends in Diversion Detection,” on … Read More

Kit Check’s Bluesight for Controlled Substances Solution Implemented at 10 OhioHealth Hospitals

Jenny HarlettPress Release

Rapid cloud-based implementation for nationally recognized health system committed to addressing drug diversion and the opioid crisis already yielding results WASHINGTON (December 16, 2019) —Kit Check, the leader in automated medication management solutions for hospitals, today announced that OhioHealth, a nationally recognized health system based in Columbus, Ohio, has implemented Bluesight for Controlled Substances across its health network to gain … Read More

Big News: Kit Check Partners with Omnicell to offer BCS

Jenny HarlettBlog

We are very excited to announce that we have entered into an agreement with Omnicell to offer Bluesight for Controlled Substances to Omnicell customers! Through this new partnership, Omnicell customers will have access to a single sign-on dashboard that aggregates information from automated dispensing cabinets and the EMR, documenting who is handling what medications, when, where, and for whom.  This … Read More

Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances

Jenny HarlettPress Release

Medication intelligence software solution supports critical need for hospitals and health systems to identify drug diversion to combat national opioid crisis MOUNTAIN VIEW, Calif.—December 9, 2019—Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, has entered into an agreement with Kit Check™ to offer Bluesight™ for Controlled Substances diversion prevention software, … Read More

Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis

Jenny HarlettBlog, News

The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny. Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play. … Read More

Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking

Jenny HarlettPress Release

WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for hospitals, today announced that Vizient has extended its agreement with the company for its Bluesight for Controlled Substances (BCS) as well as Kit Check’s kit and tray processing system. Vizient is the nation’s leading health care performance improvement company serving more than 50% of the … Read More

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Jenny HarlettPress Release

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 WASHINGTON (August 20, 2019) — Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances (Bluesight) diversion prevention and controlled substance management solution has been recognized by leading analyst firm KLAS Research in its next-generation solution … Read More

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More

New Bluesight for Controlled Substances Feature: Investigation Portfolios

Jenny HarlettBlog

We are excited to announce the launch of our newest feature for the Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Designed to support ASHP investigation guidelines, the Investigations Portfolio dashboard allows hospital diversion teams to collaborate with each other throughout the process, ensuring thorough, unbiased investigations and adherence to established procedures. Many hospitals … Read More